Physician profile
Keith G Holley
NPI 1386616183
$36,241.63
in general payments reported to CMS, 2019-2025
11 companies · $10K in 2025
The $10K reported for 2025 was more than what 76% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,882 · 2020: $1,565 · 2021: $8,211 · 2022: $2,892 · 2023: $4,862 · 2024: $3,411 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Royalty Or License: $4,527 · Food and Beverage: $2,664.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,500.00 |
| Royalty Or License | $4,527.43 |
| Food and Beverage | $2,664.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Total Joint Orthopedics, INC. | $35,228.02 | 2019-2025 | |
| Medacta USA, INC. | $282.19 | 2019-2025 | Gmk Sphere |
| Zimmer Biomet Holdings, INC. | $258.24 | 2020-2024 | Persona |
| Orthalign INC | $118.80 | 2024 | Orthalign Plus |
| Engage Uni, LLC | $114.00 | 2021 | |
| Stryker Corporation | $100.03 | 2020 | |
| Sawtooth Surgical Solutions INC | $38.64 | 2024 | |
| Horizon Therapeutics Plc | $36.18 | 2019 | |
| Think Surgical, INC. | $31.40 | 2023 | |
| Lilly USA, LLC | $20.79 | 2023 | Mounjaro |
| Fidia Pharma USA INC. | $13.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Holley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.